WebinarsNew
Deep DiveNew
Explore Business Standard
The revenue stands at ₹641.58 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 17.35 per cent from ₹776.25 crore. This corresponds to a year-on-year *(YoY) growth of 119.16 per cent.
Operating Profit stands at ₹222.89 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 27.48 per cent from ₹307.33 crore. This corresponds to a year-on-year *(YoY) growth of 546.25 per cent.
PBDT stands at ₹224.40 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 28.21 per cent from ₹312.58 crore. This corresponds to a year-on-year *(YoY) growth of 494.28 per cent.
Profit Before Tax stands at ₹197.84 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 31.18 per cent from ₹287.49 crore. This corresponds to a year-on-year *(YoY) growth of 1,026.01 per cent.
Net Profit stands at ₹147.67 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 30.56 per cent from ₹212.67 crore. This represents a 962.37 per cent year-on-year *(YoY) growth for the same year.
| Category | Q1 FY26-27 | Q1 FY25-26 | Change % | FY25-26 | FY24-25 | Change % |
|---|---|---|---|---|---|---|
| Total Revenue | 641.58 | 292.75 | 119.16 | 2,022.99 | 1,476.84 | 36.98 |
| Expenses | 418.69 | 258.26 | 62.12 | 1,448.49 | 1,153.58 | 25.56 |
| Other Income | 8.49 | 7.86 | 8.02 | 30.17 | 96.91 | -68.87 |
| Operating Profit | 222.89 | 34.49 | 546.25 | 604.66 | 420.17 | 43.91 |
| Depreciation | 26.56 | 20.19 | 31.55 | 91.74 | 65.55 | 39.95 |
| Interest | 6.97 | 4.58 | 52.18 | 23.95 | 8.30 | 188.55 |
| Profit Before Tax | 197.84 | 17.57 | 1026.01 | 488.98 | 346.33 | 41.19 |
| Tax | 50.17 | 3.67 | 1267.03 | 128.96 | 73.77 | 74.81 |
| Net Profit | 147.67 | 13.90 | 962.37 | 364.00 | 260.11 | 39.94 |
| Category | Q1 FY26-27 | Q1 FY25-26 | Change % | FY25-26 | FY24-25 | Change % |
|---|---|---|---|---|---|---|
| Total Revenue | 641.58 | 292.75 | 119.16 | 2,022.99 | 1,476.84 | 36.98 |
| Expenses | 419.00 | 258.46 | 62.11 | 1,449.74 | 1,154.54 | 25.57 |
| Other Income | 8.49 | 7.86 | 8.02 | 30.16 | 96.91 | -68.88 |
| Operating Profit | 555.12 | 226.58 | 145.00 | 603.41 | 419.21 | 43.94 |
| Depreciation | 26.56 | 20.19 | 31.55 | 91.73 | 65.54 | 39.96 |
| Interest | 6.97 | 4.58 | 52.18 | 23.95 | 8.30 | 188.55 |
| Profit Before Tax | 197.53 | 17.38 | 1036.54 | 487.73 | 345.37 | 41.22 |
| Tax | 50.17 | 3.67 | 1267.03 | 128.88 | 73.65 | 74.99 |
| Net Profit | 147.36 | 13.71 | 974.84 | 363.11 | 259.43 | 39.96 |
| Category | Q1 FY26-27 | Q4 FY25-26 | Change % |
|---|---|---|---|
| Total Revenue | 641.58 | 776.25 | -17.35 |
| Expenses | 418.69 | 468.92 | -10.71 |
| Other Income | 8.49 | 12.46 | -31.86 |
| Operating Profit | 222.89 | 307.33 | -27.48 |
| Depreciation | 26.56 | 25.09 | 5.86 |
| Interest | 6.97 | 7.21 | -3.33 |
| Profit Before Tax | 197.84 | 287.49 | -31.18 |
| Tax | 50.17 | 74.82 | -32.95 |
| Net Profit | 147.67 | 212.67 | -30.56 |
| Category | Q1 FY26-27 | Q4 FY25-26 | Change % |
|---|---|---|---|
| Total Revenue | 641.58 | 776.25 | -17.35 |
| Expenses | 419.00 | 469.35 | -10.73 |
| Other Income | 8.49 | 12.46 | -31.86 |
| Operating Profit | 555.12 | 683.92 | -18.83 |
| Depreciation | 26.56 | 25.09 | 5.86 |
| Interest | 6.97 | 7.23 | -3.60 |
| Profit Before Tax | 197.53 | 287.04 | -31.18 |
| Tax | 50.17 | 74.52 | -32.68 |
| Net Profit | 147.36 | 212.52 | -30.66 |
Data not available.
| Company | 1 Day | 1 Week | 1 Month | 3 Months | 6 Month | 1 Year |
|---|---|---|---|---|---|---|
| Neuland Labs. | -0.46% | 6.51% | 20.53% | 39.17% | 75.56% | 75.88% |
| Emcure Pharma | 1.01% | 4.26% | 12.61% | 21.67% | 35.59% | 38.86% |
| Sai Life | 0.63% | 2.49% | 14.03% | 33.46% | 58.42% | 60.69% |
| Wockhardt | -0.93% | -4.26% | 1.70% | 20.42% | 35.22% | 25.76% |
| Piramal Pharma | 1.17% | 3.91% | 24.47% | 22.08% | 30.47% | 12.62% |
| Rubicon Research | 0.06% | 7.72% | 14.81% | 74.34% | 110.65% | 163.19% |
| Acutaas Chemical | 1.26% | 0.15% | -6.59% | 15.46% | 61.93% | 147.76% |
No More Data
More